Site hosted by Angelfire.com: Build your free website today!
Dosage :
- Parenteral :
for acute cerebrovascular disorders the drug is first administered parenterally, this is then followed by oral therapy. The dose is 0,3 mg (1 ml) administered as i.v.drip or slow i.v. injection ( in 20 ml dextrose or saline ) once or twice daily alternatively, 0,3 mg ( 1 ml ) may be given intramuscularly or subcutaneously once to several times daily.
- Oral :
1 Ergotika 4,5 mg tablet preferably before breakfast or 1 to 2 mg, three times daily, unless otherwise prescribed by the physician.
Presentation :
Ergotika 1 mg tablets : Boxes of 10 strips of 10 tablets
Ergotika 4,5 mg tablets : Boxes of 3 strips of 10 tablets enteric coated.
Ergotika 0,3 mg injections : Boxes of 10 ampoules of 1 ml.

 

Composition :
Ergotika 1 mg contains Co-dergocrine mesylate 1 mg/tablet.
Ergotika 4,5 mg contains Co-dergocrine mesylate 4,5 mg/tablet enteric coated.
Ergotika injection contains Co-dergocrine mesylate 0,3 mg/ml.
Adverse reactions :
No serious side effects have been reported. Occasionally undesired effects can occur, such as nausea, gastric upset, skin eruptions, congestion of the nasalmucous membrane and orthostatic hypotension. In the majority of cases side effects disappear without specific measure being taken.
Indication :
No serious side effects have been reported. Occasionally undesired effect can occur, such as nausea, gastric upset, skin eruptions, congestion of the nasalmucous membrane and orthostatic hypotension. In the majority of cases side effects disappear without specific measure being taken.